PureIMS Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4.81M

  • Investors
  • 6

PureIMS General Information

Description

Manufacturer of dry powder inhalation products designed to offer effective pulmonary administration. The company's dry powder formulation equipment is broken up into small particles appropriately sized for deep lung deposition, which enables patients with diseases like cystic fibrosis, bronchiectasis, tuberculosis, Parkinson's Disease, or anaphylaxis to inhale and avoid the need for injection, enabling strong local pulmonary drug effects or extremely short onset of action in case of systemic applications.

Contact Information

Website
www.pureims.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ceintuurbaan Noord 152
  • 9301 NZ Roden
  • Netherlands
+31 050
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Ceintuurbaan Noord 152
  • 9301 NZ Roden
  • Netherlands
+31 050

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PureIMS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant $4.81M Completed Clinical Trials - Phase 1
5. Later Stage VC 03-Apr-2023 Completed Clinical Trials - Phase 1
4. Seed Round Completed Clinical Trials - Phase 1
3. Later Stage VC 26-Apr-2019 Completed Clinical Trials - Phase 1
2. Early Stage VC 12-Oct-2017 Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2014 Completed Startup
To view PureIMS’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PureIMS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of dry powder inhalation products designed to offer effective pulmonary administration. The company's dry p
Therapeutic Devices
Roden, Netherlands
10 As of 2026

Danbury, CT
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PureIMS Competitors (4)

One of PureIMS’s 4 competitors is MannKind, a Formerly VC-backed company based in Danbury, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MannKind Formerly VC-backed Danbury, CT
Pulmatrix Formerly VC-backed Framingham, MA
Savara Formerly VC-backed Yardley, PA
Insmed Formerly VC-backed Bridgewater, NJ
To view PureIMS’s complete competitors history, request access »

PureIMS Patents

PureIMS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4683692-A1 Breath actuated dry powder inhaler Pending 20-Mar-2023
WO-2024196247-A1 Breath actuated dry powder inhaler Inactive 20-Mar-2023
JP-2026509561-A Respiratory-operated dry powder inhaler Pending 20-Mar-2023 A61M15/0043

PureIMS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PureIMS Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boost-Up Groningen Venture Capital Minority
Carduso Capital Venture Capital Minority
University of Groningen University
European Union Government
IMDS Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

PureIMS FAQs

  • When was PureIMS founded?

    PureIMS was founded in 2014.

  • Where is PureIMS headquartered?

    PureIMS is headquartered in Roden, Netherlands.

  • What is the size of PureIMS?

    PureIMS has 10 total employees.

  • What industry is PureIMS in?

    PureIMS’s primary industry is Therapeutic Devices.

  • Is PureIMS a private or public company?

    PureIMS is a Private company.

  • What is PureIMS’s current revenue?

    The current revenue for PureIMS is .

  • How much funding has PureIMS raised over time?

    PureIMS has raised $8.78M.

  • Who are PureIMS’s investors?

    Boost-Up Groningen, Carduso Capital, University of Groningen, European Union, and IMDS are 5 of 6 investors who have invested in PureIMS.

  • Who are PureIMS’s competitors?

    MannKind, Pulmatrix, Savara, and Insmed are competitors of PureIMS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process